Brenda Libby Coleman

Array ( [id] => 322639 [patent_doc_number] => 07517872 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-14 [patent_title] => 'Compounds for the treatment of hepatitis C' [patent_app_type] => utility [patent_app_number] => 12/031844 [patent_app_country] => US [patent_app_date] => 2008-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11300 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/517/07517872.pdf [firstpage_image] =>[orig_patent_app_number] => 12031844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7680691 [patent_doc_number] => 20100105895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'METHOD FOR THE PRODUCTION OF HIGH-PURITY 4A, 5, 9, 10, 11, 12,-HEXAHYDRO-6H-BENZOFURO [3A, 3, 2-EF] [2] BENZAZEPINE, AND THE DERIVATIVES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/522323 [patent_app_country] => US [patent_app_date] => 2008-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2267 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20100105895.pdf [firstpage_image] =>[orig_patent_app_number] => 12522323 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6637765 [patent_doc_number] => 20100173892 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'Enantioselective synthesis of 6-amino-7-hydroxy-4,5,6,7-tetrahydro-imidazo[4,5,1-JK][1]-benzazepin-2[1H]-one and zilpaterol' [patent_app_type] => utility [patent_app_number] => 12/525222 [patent_app_country] => US [patent_app_date] => 2008-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13910 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20100173892.pdf [firstpage_image] =>[orig_patent_app_number] => 12525222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 296081 [patent_doc_number] => 07541352 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-02 [patent_title] => 'Compounds for the treatment of hepatitis C' [patent_app_type] => utility [patent_app_number] => 12/022541 [patent_app_country] => US [patent_app_date] => 2008-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25429 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/541/07541352.pdf [firstpage_image] =>[orig_patent_app_number] => 12022541 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6249832 [patent_doc_number] => 20100137581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'PROCESS FOR PREPARATION OF SUBSTANTIALLY PURE POLYMORPHIC FORM I OF OLANZAPINE' [patent_app_type] => utility [patent_app_number] => 12/523983 [patent_app_country] => US [patent_app_date] => 2008-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4165 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20100137581.pdf [firstpage_image] =>[orig_patent_app_number] => 12523983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4904751 [patent_doc_number] => 20080114165 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'Methods for the Preparation of {2-[(8,9)-Dioxo-2,6-diaza-bicyclo[5.2.0]-non-1(7)-en-2-yl]ethyl} Phosphonic Acid and Esters Thereof' [patent_app_type] => utility [patent_app_number] => 12/016491 [patent_app_country] => US [patent_app_date] => 2008-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5103 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20080114165.pdf [firstpage_image] =>[orig_patent_app_number] => 12016491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4840481 [patent_doc_number] => 20080280967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Substituted acylhydroxamic acids and method of reducing TNFalpha levels' [patent_app_type] => utility [patent_app_number] => 12/009182 [patent_app_country] => US [patent_app_date] => 2008-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14856 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20080280967.pdf [firstpage_image] =>[orig_patent_app_number] => 12009182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7680694 [patent_doc_number] => 20100105892 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'PURIFICATION PROCESS COMPRISING DISSOLVING AN ORGANIC COMPOUND IN CARBONATED WATER AND FREEZE-DRYING' [patent_app_type] => utility [patent_app_number] => 12/522312 [patent_app_country] => US [patent_app_date] => 2008-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3668 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20100105892.pdf [firstpage_image] =>[orig_patent_app_number] => 12522312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4765850 [patent_doc_number] => 20080177062 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'CRYSTALLINE K-252a BIS(N,N\' DIMETHYLFORMAMIDATE)' [patent_app_type] => utility [patent_app_number] => 11/972253 [patent_app_country] => US [patent_app_date] => 2008-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1974 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20080177062.pdf [firstpage_image] =>[orig_patent_app_number] => 11972253 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4808288 [patent_doc_number] => 20080171866 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-17 [patent_title] => 'CRYSTALLINE K-252a BIS(METHANOLATE)' [patent_app_type] => utility [patent_app_number] => 11/972269 [patent_app_country] => US [patent_app_date] => 2008-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1942 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20080171866.pdf [firstpage_image] =>[orig_patent_app_number] => 11972269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4765851 [patent_doc_number] => 20080177063 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'CRYSTALLINE K-252b, SODIUM SALT, HYDRATE' [patent_app_type] => utility [patent_app_number] => 11/972290 [patent_app_country] => US [patent_app_date] => 2008-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1929 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20080177063.pdf [firstpage_image] =>[orig_patent_app_number] => 11972290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4807437 [patent_doc_number] => 20080171015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-17 [patent_title] => 'Compounds for the Treatment of Hepatitis C' [patent_app_type] => utility [patent_app_number] => 11/971362 [patent_app_country] => US [patent_app_date] => 2008-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15785 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20080171015.pdf [firstpage_image] =>[orig_patent_app_number] => 11971362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4728048 [patent_doc_number] => 20080207592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Novel 1,4-benzothiazepine-1,1-dioxide derivative having improved properties, method for the production thereof, medicaments containing said compound, and use thereof' [patent_app_type] => utility [patent_app_number] => 11/970293 [patent_app_country] => US [patent_app_date] => 2008-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4336 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207592.pdf [firstpage_image] =>[orig_patent_app_number] => 11970293 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6454715 [patent_doc_number] => 20100105666 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'TRIAZABENZO (A)NAPHTHO(2,1,8-CDE) AZULENE COMPOUNDS.' [patent_app_type] => utility [patent_app_number] => 12/448627 [patent_app_country] => US [patent_app_date] => 2008-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6798 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20100105666.pdf [firstpage_image] =>[orig_patent_app_number] => 12448627 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6493671 [patent_doc_number] => 20100093699 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'COMPOUNDS AND USES THEREOF - 177' [patent_app_type] => utility [patent_app_number] => 12/520133 [patent_app_country] => US [patent_app_date] => 2007-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16599 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093699.pdf [firstpage_image] =>[orig_patent_app_number] => 12520133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6545049 [patent_doc_number] => 20100016284 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'COMPOUNDS AND USES THEREOF - 151' [patent_app_type] => utility [patent_app_number] => 12/520162 [patent_app_country] => US [patent_app_date] => 2007-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18588 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016284.pdf [firstpage_image] =>[orig_patent_app_number] => 12520162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6545030 [patent_doc_number] => 20100016283 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'COMPOUNDS AND USES THEREOF - 150' [patent_app_type] => utility [patent_app_number] => 12/520152 [patent_app_country] => US [patent_app_date] => 2007-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18765 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016283.pdf [firstpage_image] =>[orig_patent_app_number] => 12520152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6222743 [patent_doc_number] => 20100056492 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'COMPOUNDS AND USES THEREOF - 152' [patent_app_type] => utility [patent_app_number] => 12/520167 [patent_app_country] => US [patent_app_date] => 2007-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16387 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20100056492.pdf [firstpage_image] =>[orig_patent_app_number] => 12520167 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6355834 [patent_doc_number] => 20100022514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'Heterocycle Compounds and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/519319 [patent_app_country] => US [patent_app_date] => 2007-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23851 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20100022514.pdf [firstpage_image] =>[orig_patent_app_number] => 12519319 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4916493 [patent_doc_number] => 20080097094 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-24 [patent_title] => 'DIAZABICYCLIC CENTRAL NERVOUS SYSTEM ACTIVE AGENTS' [patent_app_type] => utility [patent_app_number] => 11/957424 [patent_app_country] => US [patent_app_date] => 2007-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67323 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20080097094.pdf [firstpage_image] =>[orig_patent_app_number] => 11957424 [rel_patent_id] =>[rel_patent_doc_number] =>)